Share

February 12, 2013; 80 (7) Article

ALS dysphagia pathophysiology

Differential botulinum toxin response

Domenico A. Restivo, Antonino Casabona, Alessia Nicotra, Mario Zappia, Maurizio Elia, Marcello C. Romano, Enrico Alfonsi, Rosario Marchese-Ragona
First published January 23, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318281cc1b
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
509

Share

Article Information

vol. 80 no. 7 616-620
DOI: 
https://doi.org/10.1212/WNL.0b013e318281cc1b
PubMed: 
23345638
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 10, 2012
  • Accepted October 11, 2012
  • First Published January 23, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Domenico A. Restivo, MD, PhD,
    2. Antonino Casabona, PhD,
    3. Alessia Nicotra, MD, PhD,
    4. Mario Zappia, MD,
    5. Maurizio Elia, MD,
    6. Marcello C. Romano, MD,
    7. Enrico Alfonsi, MD and
    8. Rosario Marchese-Ragona, MD, PhD
  1. Domenico A. Restivo, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Antonino Casabona, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Alessia Nicotra, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Mario Zappia, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurological Sciences

    Patents:

    1. 1) Electronic device for the measurement of movement time. Italian patent n. 01277716.2) Electronic device for self-assessment of movement time. Italian patent n. 01313213.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Maurizio Elia, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Marcello C. Romano, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Enrico Alfonsi, MD and
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Rosario Marchese-Ragona, MD, PhD
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Neurologic Unit (D.A.R.), “Nuovo Garibaldi” Hospital, Catania; Department of Bio-Medical Sciences, Section of Physiology (A.C.), and Department “G.F. Ingrassia” Area of Neurosciences (M.Z.), University of Catania, Catania, Italy; Department of Clinical Neurophysiology (A.N.), Imperial College Healthcare, London, UK; Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS) (M.E.), Troina; Neurological Division (M.C.R.), “Villa Sofia” Hospital, Palermo; Fondazione Istituto “C. Mondino” IRCCS (E.A.), Pavia; and ENT Department (R.M.-R.), University of Padova, Padova, Italy.
  1. Correspondence to Dr. Restivo: darestivo{at}libero.it
View Full Text

Article usage

Article usage: January 2013 to April 2020

AbstractFullPdfSource
Jan 2013259026Highwire
Feb 201318603055Highwire
Mar 2013284818Highwire
Apr 20132501424Highwire
May 20131551611Highwire
Jun 20137575Highwire
Jul 201310178Highwire
Aug 20139533Highwire
Sep 201310234Highwire
Oct 20137524Highwire
Nov 20136833Highwire
Dec 20136623Highwire
Jan 20148946Highwire
Feb 20144903Highwire
Mar 20146401Highwire
Apr 20146413Highwire
May 20146521Highwire
Jun 20145434Highwire
Jul 20148510Highwire
Aug 20143912Highwire
Sep 20147102Highwire
Oct 20142921Highwire
Nov 20142900Highwire
Dec 20143611Highwire
Jan 20154611Highwire
Feb 20153102Highwire
Mar 20156535Highwire
Apr 20152300Highwire
May 20151611Highwire
Jun 20152612Highwire
Jul 20153221Highwire
Aug 20153601Highwire
Sep 20152102Highwire
Oct 20154543Highwire
Nov 20155921Highwire
Dec 20153400Highwire
Jan 20163201Highwire
Feb 20164111Highwire
Mar 20164911Highwire
Apr 20163812Highwire
May 20164003Highwire
Jun 20161522Highwire
Jul 20162400Highwire
Aug 20162431Highwire
Sep 2016921Highwire
Oct 20165101Highwire
Nov 20163711Highwire
Dec 20162201Highwire
Jan 20172111Highwire
Feb 20173111Highwire
Mar 20173800Highwire
Apr 20174803Highwire
May 20173700Highwire
Jun 20171411Highwire
Jul 20172111Highwire
Aug 20171000Highwire
Sep 20171812Highwire
Oct 20173113Highwire
Nov 20173304Highwire
Dec 20171502Highwire
Jan 201828210Highwire
Feb 20182413Highwire
Mar 20183925Highwire
Apr 201869021Highwire
May 201857311Highwire
Jun 201829111Highwire
Jul 20182112Highwire
Aug 20184209Highwire
Sep 20184507Highwire
Oct 20182407Highwire
Nov 201844211Highwire
Dec 20182306Highwire
Jan 20192307Highwire
Feb 20193807Highwire
Mar 201962017Highwire
Apr 20194108Highwire
May 20192403Highwire
Jun 201930011Highwire
Jul 201938310Highwire
Aug 201927114Highwire
Sep 20193006Highwire
Oct 201967016Highwire
Nov 201948110Highwire
Dec 201936114Highwire
Jan 202042012Highwire
Feb 20202808Highwire
Mar 202039011Highwire
Apr 202028012Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me